News & Perspective

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Feb 03, 2012

Feb 03, 2012

Flu continues late-season Northern Hemisphere push

(CIDRAP News) – Flu activity in many Northern Hemisphere countries continued its late-season rise last week, with areas such as the United States, Canada, and Europe reporting steady increases.

Though flu activity overall is low, notable increases are occurring in North America, western Europe, and northern China, the World Health Organization (WHO) said today.

Jan 20, 2012

May 11, 2009

May 11, 2009

H1N1 FLU BREAKING NEWS: Cases top 4,500, Deaths in US & Costa Rica, first Chinese case, Tamiflu issues

 

WHO's novel H1N1 flu case count tops 4,500The global number of people infected with the novel H1N1 influenza (swine flu) virus rose to 4,694 from 30 countries, the World Health Organization (WHO) reported today. The count includes 1,626 cases and 48 deaths in Mexico and the 2,532 cases and 3 deaths reported in the United States as of yesterday. Canada has reported 284 cases and one death. [WHO update 25]

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»